These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8438369)

  • 1. Xenoreactive T-cell lines initiate pancreatic islet graft destruction in vivo.
    Wolf L; Gill RG
    Transplant Proc; 1993 Feb; 25(1 Pt 1):440-1. PubMed ID: 8438369
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of direct and indirect antigen presentation in the response to islet xenografts.
    Gill RG
    Transplant Proc; 1992 Apr; 24(2):642-3. PubMed ID: 1533075
    [No Abstract]   [Full Text] [Related]  

  • 3. Rejection of pancreatic islet xenografts does not require CD8+ T-lymphocytes.
    Gill RG; Coulombe M
    Transplant Proc; 1992 Dec; 24(6):2877-8. PubMed ID: 1465980
    [No Abstract]   [Full Text] [Related]  

  • 4. Cellular requirements for pancreatic islet xenograft rejection.
    Ahn M; Chang E; Chu G; Barker CF; Markmann JF
    Transplant Proc; 1995 Dec; 27(6):3302-3. PubMed ID: 8539963
    [No Abstract]   [Full Text] [Related]  

  • 5. Pancreatic islet allograft and xenograft survival in CD8+ T-lymphocyte-deficient recipients.
    Desai NM; Bassiri H; Odorico JS; Koller BH; Smithies O; Naji A; Barker CF; Markmann JF
    Transplant Proc; 1993 Feb; 25(1 Pt 2):961-2. PubMed ID: 8442280
    [No Abstract]   [Full Text] [Related]  

  • 6. Intrathymic transplantation promotes survival of islet xenografts (rat-->mouse).
    Mayo GL; Posselt AM; Campos L; Noorchashm N; Barker CF; Naji A
    Transplant Proc; 1994 Apr; 26(2):758. PubMed ID: 8171649
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of adhesion molecules in islet allo- and xenograft rejection.
    Gotoh M; Ohzato H; Fukuzaki T; Ohta Y; Nishihara M; Hasuike Y; Umeshita K; Sakon M; Yagita H; Okumura K; Miyasaka M; Monden M
    Transplant Proc; 1996 Apr; 28(2):617. PubMed ID: 8623304
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolonged survival of class I deficient mouse islet allografts but not xenografts.
    Markmann JF; Desai NM; Bassiri H; Kim JI; Barker CF
    Transplant Proc; 1994 Apr; 26(2):748. PubMed ID: 8171641
    [No Abstract]   [Full Text] [Related]  

  • 9. Intrathymic xenogeneic pancreatic islet transplantation--induction of donor-specific unresponsiveness by MHC class II peptides.
    Zeng Y; Torres M; Wang Y; Montag A; Thistlethwaite JR
    Transplant Proc; 1995 Feb; 27(1):176-7. PubMed ID: 7878961
    [No Abstract]   [Full Text] [Related]  

  • 10. Nature of tolerance induction to peripheral (extrathymic) islet allografts.
    Coulombe M; Lafferty KJ; Gill RG
    Transplant Proc; 1994 Apr; 26(2):720-1. PubMed ID: 8171624
    [No Abstract]   [Full Text] [Related]  

  • 11. The CD4+ effector cell in islet xenotransplantation is a macrophage and not a T-lymphocyte.
    Korsgren O; Wallgren A; Ridderstad A; Satake M; Möller E; Karlsson-Parra A
    Transplant Proc; 1995 Feb; 27(1):251. PubMed ID: 7878989
    [No Abstract]   [Full Text] [Related]  

  • 12. Pig islet xenografts are susceptible to "anti-pig" but not Gal alpha(1,3)Gal antibody plus complement in Gal o/o mice.
    McKenzie IF; Koulmanda M; Mandel TE; Sandrin MS
    J Immunol; 1998 Nov; 161(10):5116-9. PubMed ID: 9820477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolongation of concordant islet xenografts with leflunomide.
    Lakey JR; Yatscoff RW; Koshal A; Rajotte RV
    Transplant Proc; 1996 Apr; 28(2):816. PubMed ID: 8623414
    [No Abstract]   [Full Text] [Related]  

  • 14. Approaches to the prevention of immune destruction of transplanted pancreatic islets.
    Lafferty KJ; Hao L
    Transplant Proc; 1994 Apr; 26(2):399-400. PubMed ID: 8171476
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of humoral immunity in pancreatic islet allo- and xenograft rejection.
    Ahn M; Sohn C; Chang E; Chu G; DeMatteo RP; Barker CF; Markmann JF
    Transplant Proc; 1996 Apr; 28(2):840-1. PubMed ID: 8623428
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of a depleting anti-CD4 monoclonal antibody on T cells and fetal pig islet xenograft survival in various strains of mice.
    Mandel T; Dillon H; Koulmanda M
    Transplant Proc; 1995 Dec; 27(6):3569. PubMed ID: 8540105
    [No Abstract]   [Full Text] [Related]  

  • 17. Two new DNA synthesis inhibitors with potent immunosuppressive activity prolong allograft and xenograft survival in small and large animals.
    Goodman ER; Fiedor PS; Fein S; Sung RS; Athan E; Hardy MA
    Transplant Proc; 1996 Apr; 28(2):920-1. PubMed ID: 8623463
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction of immune unresponsiveness by intrathymic injection of allogeneic cells in a murine model.
    Sherburne CG; Onyekaba CO; Condie RM
    Transplant Proc; 1993 Feb; 25(1 Pt 1):307-11. PubMed ID: 8438313
    [No Abstract]   [Full Text] [Related]  

  • 19. Nonvascularized islet xenograft rejection in a mouse-to-rat combination where the vascularized heart is rapidly rejected.
    Fukuzaki T; Gotoh M; Hasuike Y; Tanigawa T; Nagano H; Umeshita K; Kanai T; Monden M; Mori T
    Transplant Proc; 1994 Apr; 26(2):779. PubMed ID: 7513472
    [No Abstract]   [Full Text] [Related]  

  • 20. T-cell vaccination prolongs heart but not islet allograft survival in rats.
    Papalois B; Wahoff D; Aasheim T; Clemmings S; Field J; Sutherland DE
    Transplant Proc; 1995 Dec; 27(6):3189. PubMed ID: 8539904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.